review: important information to date about ===> b cells antibody about ===> b cells &...
TRANSCRIPT
![Page 1: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/1.jpg)
REVIEW: IMPORTANT INFORMATION TO DATEREVIEW: IMPORTANT INFORMATION TO DATEABOUT ===> B cells ABOUT ===> B cells & ANTIBODY ANTIBODY--------------------------------------------------------------------------------B cells ----> Express surface Antibody
= BCR (B-cell receptor)
B cells produce ----> Antibody
B cells when ---> Plasma cells properly stimulated
Plasma cells are ----> Antibody “factories”
Note: each B cell has a single type of antigen-binding site*---------------------------------------------------------------------------------* B cells are clonal (only the antigen-binding site type per cell)
![Page 2: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/2.jpg)
LECTURE 10 GOALS:----------------------------------------------------------------------------1) Production of a pro-B cell
- IgH gene events: rearrangements
2) Production of a pre-B cell- IgH chain & surrogate light chain expression- IgL gene events: rearrangement
3) Production of a B cell- membrane versus secreted antibody
4) Generation of antibody diversity----------------------------------------------------------------------------
![Page 3: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/3.jpg)
STAGES IN THE DEVELOPMENT OF STAGES IN THE DEVELOPMENT OF NAÏVE B CELLS* B CELLS*---------------------------------------------------------------------------------------------
Receptor Cell expression Receptor
pro-B cell None - - - - - -
pre-B cell pre-BCR pre B-cell receptor
B cell BCR surface Antibody
---------------------------------------------------------------------------------------------* naïve = development independent of foreign antigen
![Page 4: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/4.jpg)
STAGES inSTAGES in naïve B CELL DEVELOPMENTB CELL DEVELOPMENT---------------------------------------------------------------------------------------------Cell Protein expressionpro-B cell BCR ( - )
pro-B cell, earlypro-B cell, late
pre-B cell pre-BCR (pre B-cell receptor)
B cell Surface Antibody---------------------------------------------------------------------------------------------
![Page 5: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/5.jpg)
STAGES inSTAGES in naïve B CELL DEVELOPMENTB CELL DEVELOPMENT---------------------------------------------------------------------------------------------Cell Protein expressionpro-B cell BCR ( - )
pre-B cellpre-B cell, large pre-BCR (pre B-cell receptor)
surrogate IgL (+) IgH chain
pre-B cell, small cytoplasmic IgH chain
B cell Surface Antibody---------------------------------------------------------------------------------------------
![Page 6: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/6.jpg)
STAGES inSTAGES in naïve B CELL DEVELOPMENTB CELL DEVELOPMENT---------------------------------------------------------------------------------------------Cell Protein expressionpro-B cell BCR ( - )
pre-B cell pre-BCR (pre B-cell receptor)
B cellnaïve immature Surface IgM (BCR expressed)
naïve mature Surface IgM & IgD (BCR expressed) ---------------------------------------------------------------------------------------------
![Page 7: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/7.jpg)
Events that must occur in producing a viable B cell:Events that must occur in producing a viable B cell:---------------------------------------------------------------------------------Sequence of proteins expressed in the formation ofnaïve mature B cells (IgM+,IgD+ B cell)
Chain Cellular expressionIgH chain cytoplasm
Surrogate cell surface: pre-BCRlight chain* surrogate light chain + IgH
IgL BCR (surface antibody): surface IgM( or )
& chains IgM & IgD-----------------------------------------------------------------------------------* Two associated proteins: VpreB and 5
![Page 8: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/8.jpg)
Events that occur in producing a functional Antibody---------------------------------------------------------------------------------MolecularEvent Consequence Cell stageDH --> JH DHJH Early pro-B cell
VH --> DHJH VHDHJH Late pro-B cell----------------------------------------------------------------------------------IgH chain & pre-BCR Large pre-B cellsurrogate IgLexpression
VL --> JL VLJL Small pre-B cell----------------------------------------------------------------------------------IgH & IgL BCR (surface Naïve immatureexpression IgM expression) B cell-----------------------------------------------------------------------------------
![Page 9: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/9.jpg)
Events that occur in producing a functional Antibody---------------------------------------------------------------------------------MolecularEvent Consequence Cell stageDH --> JH DHJH Early pro-B cell
VH --> DHJH VHDHJH Late pro-B cell----------------------------------------------------------------------------------IgH chain & pre-BCR Large pre-B cellsurrogate IgL surfaceexpression expression
VL --> JL VLJL Small pre-B cell----------------------------------------------------------------------------------IgH & IgL BCR (surface Naïve immatureexpression IgM expression) B cell-----------------------------------------------------------------------------------
![Page 10: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/10.jpg)
Events that occur in producing a functional Antibody---------------------------------------------------------------------------------Event Consequence Cell stageDH --> JH DHJH Early pro-B cell
VH --> DHJH VHDHJH Late pro-B cell---------------------------------------------------------------------------------- & surrogate IgL pre-BCR Large pre-B cell
VL --> JL VLJL Small pre-B cell----------------------------------------------------------------------------------IgH & IgL BCR, IgM Naïve immatureexpression B cell
& chains BCR: IgM & IgD Naïve immatureB cell
-----------------------------------------------------------------------------------
![Page 11: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/11.jpg)
FORMATION OF A FUNCTIONAL HEAVY CHAIN FORMATION OF A FUNCTIONAL HEAVY CHAIN (IgH (IgH chain) chain): pro-B cell events-----------------------------------------------------------------------------------DNAEvents Consequence Cell stageDH --> JH DHJH Early pro-B cell
VH --> DHJH VHDHJH Late pro-B cell
- Review: organization of the IgH gene (chromosome 14)------------------------------------------------------------------------------------
![Page 12: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/12.jpg)
U5-06-2
VH DH J H3 1 2 42 11 2
ORGANIZATION OF IgH GENE: Chr 14ORGANIZATION OF IgH GENE: Chr 14
ONE SELECTED TO MAKE UP CHUSED TO MAKE: V REGION
H
V, D, J
SEGMENTs
VARIABLEGENE
SEGMENTs
DIVERSITYGENE
SEGMENTs
JOININGGENE
SEGMENTS
CONSTANTGENE
2
= PSEUDOGENE
![Page 13: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/13.jpg)
VH DH J H3 1 2 42 11 2
EACH SEGMENT IS AN EXON
U5-07-1
D H
SEGMENTS
DIVERSITY
N = 27
GENE
JH
SEGMENTS
JOINING
N = 6
GENE
IgH GENE ORGANIZATIONIgH GENE ORGANIZATION
V H
SEGMENTS
VARIABLE
N = 65
GENE
EACH V GENE SEGMENTIS MADE UP OF ALEADER EXON AND A V EXONH
L V HLEADER
EXONSEQUENCE
"EXON"
![Page 14: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/14.jpg)
C1
EXON
C2
EXON
C3
EXON
C4 /SC
EXON
M
EXON
U5-08-1
MADE UP OF SEVERAL EXONSEACH CH GENE SEGMENT IS
V H DH J H3 1 2 42 11 2
SEGMENTs SEGMENTs SEGMENTs
VARIABLE DIVERSITY JOINING
GENE GENE GENE
M = TRANSMEMBRANE (aka TM)C = CYTOPLASMIC TAIL
SC = SECRETED FORMCARBOXY TERMINUS
SEGMENTSSEGMENTS
CONSTANTCONSTANTGENEGENE
EXON
C
EXONS MATCH w/ IgHEXONS MATCH w/ IgHconstant region domainsconstant region domains
IgH GENE CONSTANT REGION ORGANIZATIONIgH GENE CONSTANT REGION ORGANIZATION
![Page 15: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/15.jpg)
D Segment ---> J Segment REARRANGEMENT
NOTE: ALL CONSTANTSEGMENTS ARE
NOT SHOWN
DH J H 3VH1...VH 51
FIRST STEP IN FORMATION OF A FUNCTIONAL IgH GENE:FIRST STEP IN FORMATION OF A FUNCTIONAL IgH GENE:D ---> J REARRANGEMENT D ---> J REARRANGEMENT (IRREVERSIBLE DNA EVENT)
U5-10-C
ACTION OF RECOMBINASE
(INCLUDES RAG 1 AND RAG 2)(RAG = Recombination Activating Genes)
(RANDOM)
DNA deletional event
Early pro-B cell: D ---> J : RESULT: DJ
3J H5
J H6
D H
VH1...V H511
![Page 16: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/16.jpg)
V 2 -D 1 -J 5H H H
FORMATION OF FUNCTIONAL IgH HEAVY CHAIN:IRREVERSIBLE DNA REARRANGEMENT: V ----> DJ
U5-10-E
V ---> DJ REARRANGEMENT
VH31
VH 2
3
ACTION OF RECOMBINASE
(INCLUDES RAG 1 AND RAG 2)
Late pro-B cell: V ----> DJ : RESULT: VDJ
DNA deletional event
![Page 17: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/17.jpg)
ARE UNSUCCESSFULARE UNSUCCESSFUL((SUCCESSFUL = "PRODUCTIVE")SUCCESSFUL = "PRODUCTIVE")
VDJ on IgH ALLELE "A"
PRODUCTIVE
PRE-B CELLDEVELOPS
NONPRODUCTIVE
IgH ALLELE "B"REARRANGES
VDJ on IgH ALLELE "B"
PRODUCTIVE
PRE-B CELLDEVELOPS
NO FURTHER IgHREARRANGEMENT"ALLELIC EXCLUSION"
NONPRODUCTIVE
CELLDIES U5-12-1
OUTCOME IF THE IgH VDJ REARRANGEMENTSOUTCOME IF THE IgH VDJ REARRANGEMENTS
![Page 18: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/18.jpg)
FORMATION OF pre-B CELL: FORMATION OF pre-B CELL: RequirementsRequirements----------------------------------------------------------------------------- Expression of IgH chain- Expression of surrogate light chain- Surface expression of pre-BCR
VDJ
TRANSCRIPTION
3
IgH GENE
nascent mRNA
U5-11-A
![Page 19: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/19.jpg)
U5-11-B
VDJSPLICED OUT
nascent mRNA
V D J
mature mRNA AAAAAA
Splicing of IgH Heavy Chain mRNA
NOTE: DO NOT CONFUSE THE RNA SPLICING EVENT
WITH THE DNA RECOMBINATION EVENTS OF VDJ JOINING
SPLICING
contantgene exons
![Page 20: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/20.jpg)
nascent mRNA
mature mRNA for surface chain expression
DETAILED VIEW:Splicing of IgH Heavy Chain mRNA for SURFACE EXPRESSION
C1 C1 C1 C4/SC TM Cyto.
AAAAAA
Secretory-C-terminal (SC) portion of C4/SC exon not included in mRNA of chain of surface IgM
![Page 21: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/21.jpg)
AAAAAAMaturemRNA
Translation
Variableregion/domain
C1 C2 C3 C4
TM
Cyto
IgL
RELATIONSHIP OF EXONS, mRNA splicing & DOMAINSRELATIONSHIP OF EXONS, mRNA splicing & DOMAINS
DOMAINS
Protein
![Page 22: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/22.jpg)
Splicing of IgH Heavy Chain mRNA for SECRETION
nascent mRNA C1 C1 C1 C4/SC M Cyto.
mature mRNA for secretion
AAAAAA
M and Cytoplasmic exons not not includedin mRNA of chain of secreted IgM
![Page 23: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/23.jpg)
V D J
C 1
IgH PROTEIN CHAIN
CDR1 CDR2 CDR3
FR = FRAMEWORK REGIONCDR = COMPLEMENTARITY DETERMINING REGION = HVRHVR = HYPERVARIABLE REGION
REVIEW: WU-KABAT PLOT for variability vs
amino acid position
U5-11-D
VH CH
V D JC1 C2 C3 C4
DOMAINS ILLUSTRATED
<=== Regions
FR1 FR2 FR3 FR4
V REGIONH
![Page 24: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/24.jpg)
JUNCTIONS BETWEEN D & J and BETWEEN V & DJ:JUNCTIONS BETWEEN D & J and BETWEEN V & DJ:Site of diversification in 1Site of diversification in 100 amino acid sequence amino acid sequence
V
CDR1 CDR2FR1 FR2 FR3
J
C 1
FR4
V ---> DJ D ---> J
D
CDR3
Sequence variations in CDR3 affect epitope binding!
![Page 25: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/25.jpg)
IMPRECISE RECOMBINATIONIMPRECISE RECOMBINATION
T C AC A TV SEGMENT D SEGMENT
C A T T C A ---HIS-SER---
T C A --SER---
C A T T C A
A --GLN---C AU5-19-2
C A T T C A
![Page 26: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/26.jpg)
N REGION DIVERSITY: BASES ADDED at JUNCTIONSN REGION DIVERSITY: BASES ADDED at JUNCTIONS
N = A, T , C, or G
N N N IN FRAME
N NNN
ADDED BY TdT(TERMINAL
DEOXYNUCLEOTIDYLTRANSFERASE)
V
V OUT OFFRAME
D SEGMENT
D SEGMENT
V-DJJUNCTION
D-JJUNCTION
J
J
NOTE: DIVERSITY SEGMENT CAN BE READ IN MANY READING FRAMES!
![Page 27: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/27.jpg)
15:1 - 15:1 - ARE THESE N-REGION ADDITIONS IN FRAMEARE THESE N-REGION ADDITIONS IN FRAMEOR OUT-OF-FRAME?OR OUT-OF-FRAME?
N = A, T , C, or G
NN N IN FRAME
NN N IN FRAME
ADDED BY TdT(TERMINAL
DEOXYNUCLEOTIDYLTRANSFERASE)
V
V
D SEGMENT
D SEGMENT
V-DJJUNCTION
D-JJUNCTION
J
J
U5-20-1
![Page 28: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/28.jpg)
VH CHREGION REGION
CDR1 CDR2 CDR3
CDR1
CDR2
CDR3
EPITOPE
U5-11-E
SIMPLIFIED VIEW AS 6 CDRs (3 FROM IgH AND 3 FROM IgL)
MAKE UP THE SITE ON THE ANTIBODY WHERE ANTIGENIC
DETERMINANTS (EPITOPES) ARE BOUND
CHAIN, REGIONS, DOMAINS, CDR’s, EPITOPE BINDINGCHAIN, REGIONS, DOMAINS, CDR’s, EPITOPE BINDING
![Page 29: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/29.jpg)
IgHchainSurrogate
light chain
pre-B cell Receptorpre-B cell Receptor(pre-BCR)(pre-BCR)
LARGE pre-B CELL: pre-BCR EXPRESSION
Expression ofpre-BCR is atrigger to initationof IgL generearrangement:
Transition to:Small pre-B cell
![Page 30: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/30.jpg)
SMALL pre-B CELL: IgL rearrangement
IgL GENE ORGANIZATIONIgL GENE ORGANIZATION- separate genes for - separate genes for & &
- - gene: chr. 2; gene: chr. 2; gene: chr. 22 gene: chr. 22
Study
V K JK CKappa
KAPPA GENE ORGANIZATION:
KAPPA GENE REARRANGES before LAMBDA GENE
![Page 31: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/31.jpg)
EXONs Single EXON(single domain)
N = 40 N = 5
V K J K C Kappa
J K C K
KAPPA GENE ORGANIZATIONKAPPA GENE ORGANIZATION
U5-13-2
VK
L V EXONsK
![Page 32: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/32.jpg)
K
CK
VK JK C
V ---> J REARRANGEMENT
Kappa GENE
Kappa GENE
VK JK CK
Kappa GENE
ACTION OF RECOMBINASE
KAPPA LIGHT CHAIN V to J REARRANGEMENTKAPPA LIGHT CHAIN V to J REARRANGEMENTIRREVERSIBLE DNA EVENT: IRREVERSIBLE DNA EVENT: Small pre-B cell
U5-14-1
V 1K J 3K
Deletional event
![Page 33: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/33.jpg)
TRANSLATION
mature mRNA AAAAAAAAA
U5-14-2
nascent mRNA
LIGHT CHAIN mRNA TRANSCRIPTION AND TRANSLATIONLIGHT CHAIN mRNA TRANSCRIPTION AND TRANSLATION
V JK K CK
Kappa GENE
TRANSCRIPTION
mRNA splicing
VJCKAPPA IgL (LIGHT) CHAINPROTEIN:
![Page 34: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/34.jpg)
U5-15-1
VJ REARRANGEMENTSVJ REARRANGEMENTS
VJ, ALLELE "A"
PRODUCTIVE NONPRODUCTIVE
NAIVE IMMATURE B CELLDEVELOPS
KAPPA ALLELE "B"REARRANGES
VJ, ALLELE "B"
PRODUCTIVE NONPRODUCTIVE
NAIVE IMMATURE B CELLDEVELOPS
NO FURTHER IgLREARRANGEMENT"LIGHT CHAIN ISOTYPE EXCLUSION"
LAMBDA GENEREARRANGES
KAPPA GENE
ETC.
NEED PRODUCTIVE IgL REARRANGEMENT FOR FORMATION OFIMMATURE "NAIVE" B CELL
"IN FRAME" "NOT IN FRAME"
CONSEQUENCES OF "NONPRODUCTIVE KAPPA IgLCONSEQUENCES OF "NONPRODUCTIVE KAPPA IgL
(Expresses Kappa) SIMILAR TO KAPPA
![Page 35: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/35.jpg)
IgHchain
IgL expression
BCR expressionBCR expression(IgM)(IgM)
Naïve immature B CELL: BCR (IgM) EXPRESSION
![Page 36: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/36.jpg)
TRANSITION FROM NAÏVE TRANSITION FROM NAÏVE IMMATUREIMMATURE B CELL B CELL to to NAÏVE NAÏVE MATUREMATURE B CELL: B CELL: --------------------------------------------------------------------------------Simultaneous expression of IgM & IgD
- mRNA of B cell includes constant region in addition to constant region
- mRNA: termed a “long nuclear transcript”- mRNA alternative splicing results in either constant
region or constant region with the same VDJ-----------------------------------------------------------------------------------
3
VDJ
IgH GENE
VDJnascent mRNA
LONG NUCLEARTRANSCRIPT
U5-16-1
TRANSCRIPTIONTHRU MU and DELTA
![Page 37: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/37.jpg)
TRANSLATION TRANSLATION
VDJ VDJ
VDJAAAAAA
VDJMU CHAIN
VDJDELTA CHAIN
ALTERNATIVE SPLICING OF IgH mRNA produces NAÏVE MATURE B CELLALTERNATIVE SPLICING OF IgH mRNA produces NAÏVE MATURE B CELL
U5-17-1IgM
plus L CHAIN
IgD
plus L CHAIN
PROTEIN
VDJAAAAAA
SPLICINGRNA
![Page 38: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/38.jpg)
IgHchain
IgL expression
IgM expressionIgM expression
Naïve mature B CELL: IgM & IgD EXPRESSION
IgH chain
IgD expressionIgD expression
Antigen-binding sites of IgM & IgD are identical: B cell is still “clonal”
![Page 39: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/39.jpg)
Naïve AntibodyRepertoire
Mature (naïve)B cell**
IgM
IgD
![Page 40: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/40.jpg)
Naïve AntibodyRepertoire
Adaptive AntibodyRepertoire
“ Total” Antibody Repertoire = Naïve + Adaptive
Antigen
![Page 41: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/41.jpg)
QUESTION: How can the immune system deal with an almost endless number of antigens that it has never been exposed to previously?
IMMUNE SYSTEM: Creates a “pre-existing” Antibody Repertoire* prior to any antigen exposure
REPERTOIRE = Sum total of the body’s different antibodies ~=> 10 billion different antibodies
![Page 42: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/42.jpg)
CREATING THE NAÏVE ANTIBODY REPERTOIRE:CREATING THE NAÏVE ANTIBODY REPERTOIRE:CREATING DIVERSITY IN BCRCREATING DIVERSITY IN BCR----------------------------------------------------------------------------------Sources of diversity:
V D JDifferent VH’s, DH’s, JH’s IgH 65 27 6
VL’s, JL’s 40 --- 5 30 --- 4
Variations in junctions* Chain Junctions Incr. diversity- Imprecise recombination IgH 2 100- N-region diversity IgL 1 10
Various combinations of IgH and IgL---------------------------------------------------------------------------------* 10 fold incr. diversity with each junction
![Page 43: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/43.jpg)
CREATING THE NAÏVE ANTIBODY REPERTOIRE:CREATING THE NAÏVE ANTIBODY REPERTOIRE:CREATING DIVERSITY IN BCRCREATING DIVERSITY IN BCR----------------------------------------------------------------------------------Sources of diversity: Combinatorial diversity
V D J CombinationsIgH 65 27 6 10,530 40 --- 5 200 30 --- 4 120
JunctionalCombinations (x) diversity Product
IgH ~10,000 100 1,000,000 200 10 2,000 120 10 1,200----------------------------------------------------------------------------------
![Page 44: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/44.jpg)
CREATING THE NAÏVE ANTIBODY REPERTOIRE:CREATING THE NAÏVE ANTIBODY REPERTOIRE:CREATING DIVERSITY IN BCRCREATING DIVERSITY IN BCR---------------------------------------------------------------------------------
Combinatorial & Junctionaldiversity
IgH 1,000,000 2,000 1,200
[IgH (x) ] + [ IgH (x) ]
[ 106 x 2 x 103 ] + [ 106 x 1.2 x 103 ]
2x 109 + 1.2 x 109 = 3.2 x 103.2 x 1099
----------------------------------------------------------------------------------
![Page 45: REVIEW: IMPORTANT INFORMATION TO DATE ABOUT ===> B cells ANTIBODY ABOUT ===> B cells & ANTIBODY --------------------------------------------------------------------------------](https://reader035.vdocument.in/reader035/viewer/2022081520/5697c0111a28abf838ccb8c3/html5/thumbnails/45.jpg)
V D J
mature mRNA
TRANSLATION TRANSLATION
AAAAAA
V D J
IgH CHAIN PROTEIN
DRAWING THE REGIONS IN ~CORRECT PROPORTIONS
VH
CH
REGION REGION
IgH CHAIN
U5-11-C